AAAAAA

   
Results: 1-8 |
Results: 8
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults
Authors: McMahon, D Lederman, M Haas, DW Haubrich, R Stanford, J Cooney, E Horton, J Kelleher, D Ross, L Cutrell, A Lee, D Spreen, W Mellors, JW
Citation: D. Mcmahon et al., Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults, ANTIVIR TH, 6(2), 2001, pp. 105-114
Canadian labour market developments in international context: Flexibility,regulation and demand
Authors: Stanford, J
Citation: J. Stanford, Canadian labour market developments in international context: Flexibility,regulation and demand, CAN PUBL P, 26, 2000, pp. S27-S58
Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals
Authors: Amiel, C Kusnierz, JP Mouton, Y Rook, G Stanford, J Singh, M Capron, A Bahr, GM
Citation: C. Amiel et al., Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals, J CLIN IMM, 20(6), 2000, pp. 458-465
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase
Authors: Lederman, MM McKinnis, R Kelleher, D Cutrell, A Mellors, J Neisler, M Cooney, E Haas, DW Haubrich, R Stanford, J Horton, J Landay, A Spreen, W
Citation: Mm. Lederman et al., Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase, AIDS, 14(17), 2000, pp. 2635-2642
Anti-heat-shock protein 70 kDa antibodies in vascular patients
Authors: Chan, YC Shukla, N Abdus-Samee, M Berwanger, CS Stanford, J Singh, M Mansfield, AO Stansby, G
Citation: Yc. Chan et al., Anti-heat-shock protein 70 kDa antibodies in vascular patients, EUR J VAS E, 18(5), 1999, pp. 381-385
Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)
Authors: Dlugovitzky, D Bottasso, O Dominino, JC Valentini, E Hartopp, R Singh, M Stanford, C Stanford, J
Citation: D. Dlugovitzky et al., Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172), RESP MED, 93(8), 1999, pp. 557-562
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
Authors: Staszewski, S Morales-Ramirez, J Tashima, KT Rachlis, A Skiest, D Stanford, J Stryker, R Johnson, P Labriola, DF Farina, D Manion, DJ Ruiz, NM
Citation: S. Staszewski et al., Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults, N ENG J MED, 341(25), 1999, pp. 1865-1873
Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth
Authors: Trussell, J Vaughan, B Stanford, J
Citation: J. Trussell et al., Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth, FAM PLAN PE, 31(5), 1999, pp. 246
Risultati: 1-8 |